Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abrysvo
Pharma
Pfizer's RSV vaccine benefits immunocompromised adults
Pfizer said a single dose of Abrysvo generated strong neutralizing antibodies against both subtypes of RSV in all four cohorts of trial participants.
Angus Liu
Aug 12, 2024 10:20am
With new CDC guidelines, RSV market value falls sharply: report
Jul 29, 2024 12:04pm
UK selects Pfizer over GSK to supply RSV vaccines for 2 years
Jun 24, 2024 11:19am
GSK's Arexvy has expanded its label into adults ages 50-59
Jun 7, 2024 6:45pm
Pfizer to establish a direct-to-consumer online platform
May 1, 2024 11:22am
GSK's Arexvy dominates RSV market ahead of new competition
May 1, 2024 11:20am
